United Therapeutics (STU:UTH) Accumulated Depreciation : €-407 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is United Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

United Therapeutics's quarterly accumulated depreciation declined from Sep. 2023 (€-394 Mil) to Dec. 2023 (€-393 Mil) but then increased from Dec. 2023 (€-393 Mil) to Mar. 2024 (€-407 Mil).

United Therapeutics's annual accumulated depreciation increased from Dec. 2021 (€-303 Mil) to Dec. 2022 (€-361 Mil) and increased from Dec. 2022 (€-361 Mil) to Dec. 2023 (€-393 Mil).

United Therapeutics Accumulated Depreciation Historical Data

The historical data trend for United Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Therapeutics Accumulated Depreciation Chart

United Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-242.46

-254.25

-303.02

-361.27

-392.66

United Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-369.77	-377.32	-394.01	-392.66	-407.47

United Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

United Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of United Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

United Therapeutics (STU:UTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » United Therapeutics Corp (STU:UTH) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

UTHR:USA

Address

1040 Spring Street, Silver Spring, MD, USA, 20910

Website

https://www.unither.com

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

United Therapeutics (STU:UTH) Headlines

No Headlines